Searched for
BIOPHARMACEUTICAL MANUFACTURING
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- US stock market futures today: Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? Dow drops 280 points as oil tops $120— can AI spending offset rising inflation fears and Fed uncertainty?Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? The US stock market futures today are sending a sharp, layered signal....
- US stock market today: why Dow Jones crashing big while S&P 500 and Nasdaq are rising? Dow down by 200 points as oil surge, Fed jitters, and Big Tech earnings split market directionUS stock market today: Why Dow Jones Industrial Average falls while S&P 500 and Nasdaq Composite hold steady? US stock market today shows a...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- China pulls ahead in biologics race, forcing Indian drugmakers to rethink strategyIndia's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...
- Biocon Biologics sees Biopharma SHAKTI as major boost for India’s biosimilar ambitionsIndia's biopharmaceutical sector receives a significant boost with the Union Budget's ₹10,000 crore Biopharma SHAKTI programme. This initia...
- Covid-19: It may take Haffkine 12 months to start producing Covaxin“Any vaccine is a biological product and has to be produced with the utmost precaution of biosafety,” Sandeep Rathod, CEO of Haffkine Bio-P...
- Incoming Narendra Modi government represents opportunity to US business: PhRMAIncoming Modi-led govt represents an 'excellent opportunity' for American industries to strengthen & rekindle their relationships with Indi...
- GE Healthcare to acquire PAA LaboratoriesGE Healthcare said that it has reached an agreement to acquire PAA Laboratories that develops and supplies cell culture media for biomedica...
- Samsung Group, Quintiles to form drug ventureSamsung Electronics, the world's biggest manufacturer of flat screen televisions and computer memory chips, will hold 40 per cent of the ve...
- Biocon acquires 49% Cuban partner CIMAB’s stake in JVBiocon has fully acquired the joint venture Biocon Biopharmaceuticals from its Cuban partner CIMAB.
- Reliance Life Sciences bets big on biosimilarsReliance Life Sciences (RLS), a company promoted by Reliance Industries’ chairman, Mukesh Ambani, is looking at biopharmaceuticals as a hug...
- Intas mfg unit gets EU-GMP certificationIntas Biopharmaceuticals Ltd (IBPL) has received European Union-good manufacturing practices (EU-GMP) certification for its manufacturing f...
Load More
